Navigation Links
Rosetta Genomics Reports First Quarter 2008 Financial Results
Date:5/21/2008

d development, net $ 6,400 $ 4,781 $ 2,389 $ 1,161

Marketing and business

development 1,742 1,504 511 375

General and administrative 2,903 1,860 829 680

Operating loss 11,045 8,145 3,729 2,216

Financial expenses (income),

net 3,616 (538) 149 (200)

Net loss $ 14,661 $ 7,607 $ 3,878 $ 2,016

Basic and diluted net loss

per Ordinary share $ 1.32 $ 2.98 $ 0.33 $ 0.23

Weighted average number of

Ordinary shares used to

compute basic and diluted

net loss per Ordinary share 11,142,149 2,551,860 11,920,401 8,874,841

Contact: Media

Rachel Spielman

T: +1-212-583-2714

E: media@rosettagenomics.com

Investors

Ron Kamienchick

T: +1-646-509-1893

E: investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 DuPont welcomes 48 of the ... DuPont National AgriScience Teachers Ambassador Academy this week (NATAA) ... Md. , The NATAA “Ag Academy” is ... a special project of the National FFA Foundation ... (NAAE) . The highly recommended agriscience teachers, who ...
(Date:6/18/2013)... -- regulated information — Global biopharmaceutical company UCB, Inc. and ... launch of a new Pledge campaign for people with ... empowers the millions of Americans living with ... commitment to demand more: greater understanding of the condition, ... partial-onset seizure control.  More information is available at ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the "Injectable Drug ... Nanoparticles], Devices [Disposables & Reusable, Fillable & ... & Therapeutics [Diabetes & Oncology] - Global ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... Selexis SA, a Swiss-based biotechnology company with technologies ... yield and stable mammalian cell lines for therapeutic ... from the Company will be participating in the ... held Jun 27-30 in Washington, D.C. at the ...
... of a new quasiparticle called the "hybrid plasmon ... photonic circuits and optical computing for the 21st ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ... generation on-chip optical communication systems. "We ...
... Inc. (Nasdaq: AMLN ) will be presenting at the ... 2011, at 12:20 p.m. ET / 9:20 a.m. PT ... Life Sciences Conference on Wednesday, June 8, 2011, at 10:00 a.m. ... New York.  Daniel M. Bradbury, president and chief executive officer ...
Cached Biology Technology:Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC 2Nanoscale waveguide for future photonics 2Nanoscale waveguide for future photonics 3Nanoscale waveguide for future photonics 4
(Date:6/19/2013)... The Flemish plant scientist Marc Van Montagu (born 1933) ... with the American scientists Mary-Dell Chilton and Robert T. ... by the US Secretary of State, John Kerry. The ... and agriculture" - gives the award annually to one ... social importance for the quality, quantity or availability of ...
(Date:6/19/2013)... , June 19, 2013 AT&T ... the upcoming launch of the ultimate workhorse among ... Terrain™. As one of the most ruggedized phones ... NEC Terrain embodies toughened versatility and business-ready features.  ... to keep workforces moving forward, while also keeping ...
(Date:6/19/2013)... the most perfectly spherical large objects in nature may ... new study. It appears in ACS, journal Langmuir ... Julyan Cartwright, Antonio G. Checa and Marthe Rousseau point ... have perhaps the most perfectly spherical, or ball-like, shape ... without a microscope. Pearls develop as nacre (mother of ...
Breaking Biology News(10 mins):World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5
... the first time anywhere, a researcher at the Hebrew University ... of neurons in the brain of a mammal. , ... Alexander Silberman Institute of Life Sciences at the Hebrew University, ... develop from an undifferentiated cellular sphere into a rich and ...
... lack a single enzyme in their brains are more adept ... figure out that their environment has changed, a team led ... , The results, appearing today in the online edition ... mechanism of learning in the brain, which might serve in ...
... imaging (MRI), radiologists can better predict the likelihood of ... cord injuries (SCI), according to a study published in ... "Our study demonstrates that the possibility and extent of ... hours after injury by rigorous assessment of MR images," ...
Cached Biology News:A first -- Hebrew University scientist observes brain cell development in 'real time' 2'Smart' mice teach scientists about learning process, brain disorders 2Researchers use MRI to predict recovery after spinal cord injury 2
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
This monoclonal antibody recognizes the light chain of human Factor XII and at 100 nM inhibits 50% of Factor XII activity. It may be used in ELISA to detect human Factor XII and in coagulation assay...
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Disrupts biological cells for DNA ... 96 well plates (includes 96 well ... consistent lysis across the entire plate ... wells). Can be used for ...
Biology Products: